Your browser is no longer supported. Please, upgrade your browser.
GWPH GW Pharmaceuticals plc daily Stock Chart
GW Pharmaceuticals plc
Index- P/E- EPS (ttm)-8.90 Insider Own0.62% Shs Outstand31.69M Perf Week3.36%
Market Cap5.67B Forward P/E- EPS next Y-3.63 Insider Trans-94.00% Shs Float2.25M Perf Month14.76%
Income-261.80M PEG- EPS next Q-2.37 Inst Own80.80% Short Float- Perf Quarter19.12%
Sales47.70M P/S118.84 EPS this Y78.50% Inst Trans-0.45% Short Ratio- Perf Half Y38.40%
Book/sh20.76 P/B8.62 EPS next Y60.80% ROA- Target Price224.17 Perf Year19.04%
Cash/sh16.46 P/C10.87 EPS next 5Y- ROE- 52W Range90.14 - 196.00 Perf YTD83.67%
Dividend- P/FCF- EPS past 5Y-22.00% ROI-10.40% 52W High-8.73% Beta2.73
Dividend %- Quick Ratio7.20 Sales past 5Y-26.00% Gross Margin78.70% 52W Low98.45% ATR6.61
Employees791 Current Ratio7.80 Sales Q/Q1190.60% Oper. Margin- RSI (14)54.47 Volatility3.25% 3.90%
OptionableYes Debt/Eq0.00 EPS Q/Q26.90% Profit Margin- Rel Volume0.95 Prev Close175.05
ShortableYes LT Debt/Eq0.01 EarningsMay 06 AMC Payout- Avg Volume471.90K Price178.88
Recom1.80 SMA203.15% SMA505.59% SMA20022.56% Volume449,609 Change2.19%
May-07-19Upgrade Oppenheimer Perform → Outperform
May-07-19Reiterated Guggenheim Buy $186 → $222
May-07-19Reiterated Cantor Fitzgerald Overweight $196 → $229
Mar-18-19Reiterated Cantor Fitzgerald Overweight $193 → $196
Jan-02-19Initiated JP Morgan Overweight $134
Nov-05-18Resumed Piper Jaffray Overweight
Sep-28-18Reiterated BofA/Merrill Buy $181 → $197
Sep-07-18Resumed Morgan Stanley Overweight
Aug-15-18Initiated Stifel Buy $181
Aug-08-18Reiterated Cantor Fitzgerald Overweight $235 → $211
Apr-19-18Reiterated Cantor Fitzgerald Overweight $192 → $205
Feb-06-18Reiterated Cantor Fitzgerald Buy $208 → $192
Dec-14-17Upgrade Goldman Neutral → Buy
Oct-06-17Resumed Goldman Neutral
Aug-17-17Initiated Evercore ISI Outperform $154
Aug-08-17Downgrade Maxim Group Buy → Hold
Apr-21-17Initiated Maxim Group Buy $135
Dec-05-16Reiterated Cantor Fitzgerald Buy $182 → $208
Oct-07-16Initiated Goldman Buy
Oct-04-16Resumed Leerink Partners Outperform $162
May-20-19 10:00AM  GW Pharmaceuticals PLC (GWPH) Is Up 1.6% in One Week: What You Should Know Zacks
May-16-19 07:45PM  The Smartest People on Wall Street Are Buying These 3 Stocks -- Should You Follow? Motley Fool
01:48PM  If You Had Bought GW Pharmaceuticals (NASDAQ:GWPH) Stock Five Years Ago, You Could Pocket A 171% Gain Today Simply Wall St.
06:52AM  Aurora Cannabis reverses early losses, but Tilray turns lower in afternoon trade MarketWatch
May-13-19 09:07PM  Edited Transcript of GWPH.O earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents
07:59AM  3 Strong Buy Cannabis Stocks Set For Rapid Growth TipRanks
May-12-19 09:22AM  The Week In Cannabis: A&F Tries CBD, GW Pharma Soars On Results, Denver Decriminalizes Mushrooms Benzinga
May-10-19 11:34AM  Marijuana ETFs Head-to-Head Zacks
10:58AM  The Zacks Analyst Blog Highlights: Scott's Miracle Grow, GW Pharmaceuticals, Canopy Growth, Tilray and Aurora Cannabis Zacks
10:51AM  The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Scotts Miracle-Gro, Ambev, International Game Technology and Ubisoft Entertainment Zacks
09:30AM  Has GW Pharmaceuticals (GWPH) Outpaced Other Medical Stocks This Year? Zacks
May-09-19 08:35AM  GW Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019 GlobeNewswire
08:05AM  5 Best Stocks to Buy for Sinful Gains This May Zacks
May-08-19 08:16AM  Marijuana Stocks: 5 Facts You Need to Know About GW Pharmaceuticals Quarterly Results Motley Fool
07:53AM  The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split Benzinga
May-07-19 07:46PM  Marijuana Medicine: GW Pharmaceuticals Market Opportunity Could Double Motley Fool
01:55PM  Dow falls 500 points as stocks retreat for second day on U.S.-China tariff worries MarketWatch
11:40AM  Analysts Raise Price Targets On GW Pharma's Positive Earnings, Epidiolex Results Benzinga
10:23AM  GW Pharma's CBD Drug Epidiolex Could Secure Label Expansion Following Positive Trial Results Benzinga
09:50AM  GW Pharmaceuticals Stock Could Aim for $235 Or Higher! InvestorPlace
08:20AM  The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex Benzinga
08:20AM  GW Pharma shares soar 9% premarket as Oppenheimer upgrades to outperform MarketWatch
07:53AM  Jim Cramer Shares His Thoughts On Blackstone, General Dynamics, GW Pharma And More Benzinga
May-06-19 05:29PM  GW Pharmaceuticals Earnings: GWPH Stock Gains as Q1 Sales Surge 1200% InvestorPlace
05:12PM  Biotech Stock Pops After Cannabis Medicine Outsells Expectations Investor's Business Daily
05:12PM  GW Pharmaceuticals stock rises after earnings MarketWatch
04:23PM  GW Pharmaceuticals stock rises 6% after positive CBD drug trial MarketWatch
04:01PM  GW Pharmaceuticals Reports Positive Phase 3 Pivotal Trial Results for EPIDIOLEX® (cannabidiol) Oral Solution in Patients with Seizures Associated With Tuberous Sclerosis Complex GlobeNewswire
04:01PM  GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2019 GlobeNewswire
04:00PM  GW Pharma's epilepsy drug meets main goal in late-stage trial Reuters
09:14AM  GW Pharmaceuticals Q2 Earnings Preview Benzinga
05:07AM  Can Epidolex Drive GW Pharmaceuticals' (GWPH) Q2 Earnings? Zacks
May-05-19 02:15PM  The Week In Cannabis News: Curaleaf Buys Cura Partners, Canopy Buys C3, Organigram Applies For Nasdaq Listing Benzinga
11:41AM  These 5 Pot Stocks Have the Most Cash Motley Fool
May-04-19 05:44PM  Edison Research Sees $140B Potential In Cannabis Benzinga
May-03-19 08:21AM  3 of the Biggest Pot Stocks Have a Lot to Prove Motley Fool
May-02-19 02:18PM  5 Biotech Stocks With Near-Term Catalysts Ahead Benzinga
10:13AM  The Zacks Analyst Blog Highlights: GW, Innovative Industrial, Canopy, Aurora and KushCo Zacks
07:00AM  GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol) oral solution, CV at the 2019 American Academy of Neurology Annual Meeting GlobeNewswire
May-01-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Dips More Than Broader Markets: What You Should Know Zacks
07:50AM  Invest Carefully in Rosy But Risky Marijuana Industry Zacks
Apr-30-19 12:59PM  Disruptive GW Pharmaceuticals Is Exempt from Big Pharmas Volatility InvestorPlace
Apr-29-19 02:58PM  Cannabis stocks mixed with Aleafia falling after earnings, Canopy updates on NYC hemp plans MarketWatch
Apr-28-19 05:00PM  3 Top Biotech Stocks to Buy Right Now Motley Fool
11:25AM  The Week In Cannabis: Conferences, Clean Slate Act, Earnings, Aurora, Canopy-Acreage And More Benzinga
Apr-26-19 01:17PM  The smart money is telling Canopy Growth investors to be careful MarketWatch
09:58AM  Were Hedge Funds Right About Flocking Into GW Pharmaceuticals plc (GWPH) ? Insider Monkey
07:35AM  Cannabis stocks fall but Valens GroWorks, Hexo and Cresco Labs buck the trend MarketWatch
Apr-25-19 05:50PM  GW Pharmaceuticals PLC (GWPH) Gains As Market Dips: What You Should Know Zacks
Apr-24-19 07:16AM  Cannabis stocks take a breather as Jefferies reiterates CannTrust is a conviction buy MarketWatch
Apr-23-19 01:40PM  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending March 31, 2019 and Host Conference Call on May 6, 2019 GlobeNewswire
09:56AM  Edited Transcript of GWPH.O earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
07:23AM  Canopy Growth leads cannabis stocks higher after GMP upgrades to buy MarketWatch
Apr-20-19 10:51AM  Is the Marijuana Industry Recession-Proof? Motley Fool
Apr-19-19 09:31AM  Cannabis stocks pare early gains as Canopy secures future foothold in the U.S. MarketWatch
09:15AM  So Far, So Good for Earnings Season Zacks
08:21AM  16 Marijuana 4/20 Facts That Show How Far the Cannabis Movement Has Come Motley Fool
Apr-18-19 09:31AM  Can Boston Scientific's (BSX) Steady Growth Aid Q1 Earnings? Zacks
Apr-17-19 11:13AM  Can Core MedSurg Segment Drive Stryker's (SYK) Q1 Earnings? Zacks
Apr-16-19 07:43PM  3 Top Healthcare Stocks to Buy in April Motley Fool
12:28PM  5 Marijuana Stocks Wall Street Is Most Bullish On Kiplinger
08:35AM  Cannabis stocks slammed as Aphrias quarterly loss weighs on sector MarketWatch
08:30AM  CBD Company to Research Now ACCESSWIRE
Apr-15-19 08:35AM  Will Abbott's (ABT) Steady Overall Growth Aid Q1 Earnings? Zacks
Apr-14-19 02:00PM  Better Buy: GW Pharmaceuticals vs. Cara Therapeutics Motley Fool
Apr-11-19 05:50PM  GW Pharmaceuticals PLC (GWPH) Stock Moves -0.28%: What You Should Know Zacks
04:05PM  GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Appointment of Darren Cline as U.S. Chief Commercial Officer GlobeNewswire
09:06AM  4 Stocks Giving Investors Direct Exposure to CBD Motley Fool
08:26AM  9 High-Risk Stocks to Buy for Massive Rewards InvestorPlace
Apr-10-19 12:54PM  Bulls And Bud Of The Week: CB2 Insights And Dr. Kerklaan's Therapeutics Benzinga
Apr-09-19 03:42PM  Zogenix shares down 23% after FDA refuses to review companys marketing application for seizure drug MarketWatch
03:20PM  Enormous Put Trade Crosses on GrubHub Schaeffer's Investment Research
10:29AM  Zogenix Gets Refusal to File Letter From FDA for Seizure Drug Zacks
09:14AM  GW Pharmaceuticals plc (NASDAQ:GWPH): Financial Strength Analysis Simply Wall St.
09:05AM  FDA Rejects Regulatory Filing For Zogenix Epilepsy Drug; GW Pharma Moves In Sympathy Benzinga
09:02AM  Why Zogenix Stock Is Getting Crushed Today Motley Fool
05:00AM  3 CBD Companies That Could Win a Wild West Showdown in the Hemp Market
Apr-08-19 05:40PM  Zogenix's seizure drug filing fails to pass U.S. FDA scrutiny Reuters
03:15PM  4 Marijuana Stocks to Watch in 2019 Zacks
09:30AM  Is GW Pharmaceuticals (GWPH) Stock Outpacing Its Medical Peers This Year? Zacks
Apr-07-19 11:41AM  9 Things You Must Know About CBD Before Investing in Pot Stocks Motley Fool
09:46AM  Cannabis stocks mixed ahead of bill proposing protections for weed companies MarketWatch
Apr-05-19 04:08PM  CBD Is the New Marijuana. But Dont Buy Into the Craze for Hemp Stocks.
01:18PM  Best Performing ETFs of the First Quarter Zacks
Apr-04-19 08:15AM  Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals Motley Fool
Apr-03-19 10:15PM  Better Buy: Medical Marijuana vs. GW Pharmaceuticals Motley Fool
Apr-02-19 07:07AM  4 Biotech Stocks With Major Catalysts in April Motley Fool
Apr-01-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know Zacks
Mar-30-19 10:06AM  3 Safe Stocks to Play the CBD Craze Motley Fool
Mar-27-19 11:10AM  Marijuana ETF Outperforms in Q1: 6 Stocks Leading the Rally Zacks
Mar-26-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Outpaces Stock Market Gains: What You Should Know Zacks
Mar-25-19 10:00AM  Here's Why GW Pharmaceuticals PLC (GWPH) is a Great Momentum Stock to Buy Zacks
Mar-22-19 09:10AM  US Marijuana Industry to Flourish in 2019: Who Gains? Zacks
Mar-21-19 08:30AM  How Cannabis is Going 'Greener' ACCESSWIRE
Mar-20-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Gains As Market Dips: What You Should Know Zacks
01:45PM  These Four Marijuana Stocks Are Bringing The Heat On Wednesday ACCESSWIRE
Mar-18-19 03:54PM  Buy Marijuana Stocks Now? You'd Have to Be Stoned. Kiplinger
12:56PM  2 Hemp Stocks for Investors Looking for Something Different
08:21AM  2 Brand-Name Pot Stocks That Will Lose Money in 2020 Motley Fool
07:46AM  GW Pharma announces sale of priority review voucher for $105 million MarketWatch
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of glioblastoma, neonatal hypoxic-ischemic encephalopathy, and schizophrenia. Further, the company has license and development agreements with Almirall S.A.; Bayer HealthCare AG; Ipsen Biopharm Ltd; and Neopharm Group. It primarily operates in Europe, the United Kingdom, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tovey Christopher J.Chief Operating OfficerMay 15Option Exercise3.291,2003,9483,703May 17 07:00 PM
Tovey Christopher J.Chief Operating OfficerMay 15Sale15.011,20018,0122,503May 17 07:00 PM
Gangolli Julian SPresident, North AmericaMay 10Option Exercise2.26671,9281,517,239778,476May 14 09:00 PM
Gangolli Julian SPresident, North AmericaMay 10Sale14.84671,9289,973,283106,548May 14 09:00 PM
Tovey Christopher J.Chief Operating OfficerMay 07Option Exercise0.00200,736261203,239May 09 08:01 PM
George Adam D.SecretaryMay 07Option Exercise0.00258,324336268,324May 09 08:04 PM
George Adam D.SecretaryMay 07Sale16.10258,3244,159,01610,000May 09 08:04 PM
Tovey Christopher J.Chief Operating OfficerMay 07Sale16.14200,7363,239,8792,503May 09 08:01 PM
Gover Justin D.Chief Executive OfficerMar 15Option Exercise0.0047,85162564,960Mar 19 07:00 PM
Gover Justin D.Chief Executive OfficerMar 15Sale14.0123,400327,834541,541Mar 19 07:00 PM
Secor AliciaDirectorMar 13Sale14.2090012,78019,272Apr 12 05:30 PM
MACKEY CATHERINE JDirectorMar 13Sale14.3988812,77819,284Mar 15 09:15 PM
GUY GEOFFREY W DRExecutive ChairmanMar 04Sale14.75900,00013,275,0008,141,521Mar 05 09:05 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Option Exercise1.07576,000618,5099,041,521Mar 05 09:05 PM
Brown CabotDirectorMar 01Option Exercise3.5548,540172,21855,740Mar 05 09:09 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Sale14.38576,0008,281,2358,465,521Mar 01 08:01 PM
Brown CabotDirectorMar 01Sale14.3852,104749,0463,636Mar 05 09:09 PM
Knappertz VolkerChief Medical OfficerMar 01Sale14.463,73253,9658,736Mar 05 09:06 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Sale14.49300,0004,347,000103,925Mar 05 09:05 PM
Gangolli Julian SPresident, North AmericaFeb 26Option Exercise0.0011,25615112,548Feb 28 05:09 PM
Giacobello Scott M.Chief Financial OfficerFeb 26Option Exercise0.0010,4041415,768Feb 28 05:00 PM
Snyder Douglas B.Chief Legal OfficerFeb 26Option Exercise0.009,612129,612Feb 28 05:00 PM
Gover Justin D.Chief Executive OfficerFeb 26Option Exercise0.0022,44029392,885Feb 28 05:02 PM
Knappertz VolkerChief Medical OfficerFeb 26Option Exercise0.008,4361116,608Feb 28 05:05 PM
Gover Justin D.Chief Executive OfficerFeb 26Sale12.4511,112138,328381,773Feb 28 05:02 PM
Snyder Douglas B.Chief Legal OfficerFeb 26Sale12.434,64457,7034,968Feb 28 05:00 PM
Giacobello Scott M.Chief Financial OfficerFeb 26Sale12.455,23265,12410,536Feb 28 05:00 PM
Knappertz VolkerChief Medical OfficerFeb 26Sale12.464,14051,56812,468Feb 28 05:05 PM
Gangolli Julian SPresident, North AmericaFeb 26Sale12.456,00074,696106,548Feb 28 05:09 PM
Gover Justin D.Chief Executive OfficerFeb 13Sale12.5022,620282,750370,445Feb 15 04:31 PM
Secor AliciaDirectorJan 03Option Exercise0.003,580520,172Mar 15 09:23 PM
Brown CabotDirectorJan 03Option Exercise0.003,580523,808Mar 15 09:16 PM
MACKEY CATHERINE JDirectorJan 03Option Exercise0.003,580520,172Mar 15 09:15 PM
Gover Justin D.Chief Executive OfficerJan 02Sale8.3322,620188,407393,065Jan 04 04:15 PM
Gover Justin D.Chief Executive OfficerDec 20Option Exercise0.0045,24059415,685Dec 26 04:15 PM
George Adam D.SecretaryNov 21Option Exercise0.0010,0001310,000Nov 23 04:30 PM